" To patent or not to patent? The case of Novartis' cancer drug Glivec in India"

Globalization and Health

Volumn 10, Issue 1, 2014, Pages

  Gabble, Ravinder ^a   Kohler, Jillian C ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Drug industry; Generic drugs; Glivec; India; Novartis; Patents; Pharmaceuticals; TRIPS agreement

Indexed keywords

IMATINIB; ANTINEOPLASTIC AGENT; BENZAMIDE DERIVATIVE; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

BIOAVAILABILITY; CANCER; DRUG; LEGAL SYSTEM; PHARMACEUTICAL INDUSTRY;

ARTICLE; CHRONIC MYELOID LEUKEMIA; COURT; DRUG EFFICACY; DRUG INDUSTRY; GASTROINTESTINAL STROMAL TUMOR; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE NEED; INDIA; KNOWLEDGE; LAW SUIT; MEDICAL LITERATURE; PATENT; PRIORITY JOURNAL; PUBLIC HEALTH; HUMAN; LEGAL ASPECT;

INDIA;

ANTINEOPLASTIC AGENTS; BENZAMIDES; DRUG INDUSTRY; HUMANS; INDIA; PATENTS AS TOPIC; PIPERAZINES; PYRIMIDINES;

EID: 84891518596     PISSN: None     EISSN: 17448603     Source Type: Journal    
DOI: 10.1186/1744-8603-10-3     Document Type: Article

References (22)

1. IMS announces 17 countries Now rank as high-growth 'Pharmerging' markets; forecast to contribute nearly half of industry growth by 2013. http://www.imshealth.com/portal/site/ims/menuitem.d248e29c86589c9c30e81c033 208c22a/?vgnextoid=01624605b5367210VgnVCM100000ed152ca2RCRD.
2. India's drug-patent rules: test cases. http://www.economist.com/blogs/schumpeter/2012/09/indias-drug-patent-rules.
3. Taking pains Indian patent rules infuriate big pharma. http://www.economist.com/node/21562226?zid=318&ah=ac379c09c1c 3fb67e0e8fd1964d5247f.
4. Lee L. Trials and TRIPS-ulations: Indian patent law and Novartis AG v. Union of India. Berkeley Technol Law J 2008, 28(298):281-290.
5. Mudur G. Final hearings begin in epic legal battle over Novartis drug in India. BMJ 2012, 345(6257):1-2.
6. Billingsley M. Novartis challenges India's drug patent laws in supreme court. BMJ 2012, 344(1279):1.
7. Inside story - India: human lives vs. Pharma profits. http://www.youtube.com/watch?v=F1U-1bjcYE8.
8. Médecins sans Frontières Will the Lifeline of Affordable Medicines for Poor Countries be cut? Consequences of Medicines Patenting in India (Briefing Document) 2005, Geneva, Switzerland: Médecins Sans Frontières, Médecins Sans Frontières Campaign for Access to Essential Medicines, Médecins sans Frontières.
9. Médecins sans Frontières Q&A: patents in India and the Novartis case. http://www.doctorswithoutborders.org/publications/article.cfm?id=5769&cat=briefing-documents, Médecins sans Frontières.
10. Hannon E. How an Indian patent case could shape the future of generic drugs. Time Mag 2012, http://world.time.com/2012/08/21/how-an-indian-patent-case-could-shape-the-future-of-generic-drugs/.
11. Ecks S. Global pharmaceutical markets and corporate citizenship: the case of Novartis' anti-cancer drug glivec. BioSocieties 2008, 3:165-181.
12. Basheer S, Reddy TP. The " efficacy" of Indian patent law: ironing out the creases in section 3(d). SCRIPTed 2008, 5(2):232-266.
13. Times of India Trade and Development Center 2000, India: Country Study, Times of India.
14. Redwood H. New Horizons in India: The Consequences of Patent Protection 1994, England: Oldwicks Press.
15. Roderick P, Pollock AM. India's patent laws under pressure. Lancet 2012, 380(9846):e2-e4. 10.1016/S0140-6736(12)61513-X, 22988579.
16. Chandra R. '3(d)' effect: the novartis-glivec case. Econ Polit Wkly 2011, XLVI(37):13-15.
17. Albutt J. Novartis loses battle for patent protection for Glivec cancer drug in India. http://www.mondaq.com/india/x/237788/Patent/Novartis+Loses+Battle +For+Patent+Protection+For+Glivec+Cancer+Drug+In+India.
18. Lofgren H. Novartis vs. the government of India: patents and public health. http://www.eastasiaforum.org/2013/04/26/novartis-vs-the-government-of-india-patents-and-publichealth/.
19. The Associated Press India's top court rejects Novartis cancer drug patent bid. CBC News Health 2013, http://www.cbc.ca/news/world/india-s-top-court-rejects-novartis-cancer-drug-patent-bid-1.1362212, The Associated Press.
20. Chatterjee P. Novartis loses patent bid: lessons from India's 3(d) experience. Intellectual Property Watch 2013, http://www.ip-watch.org/2013/04/01/novartis-loses-patent-bid-lessons-from-indias-3d-experience/.
21. Venkatesan J. Landmark verdict gives big boost to cancer patients. The Hindu 2013, http://www.thehindu.com/news/national/landmark-verdict-gives-big-boost-to-cancer-patients/article4569056.ece.
22. Taylor L. Novartis loses Indian glivec patent case. Pharm Times 2013, http://www.pharmatimes.com/article/13-04-02/Novartis_loses_Indian_Glivec_patent_case.aspx.